Please login to the form below

Not currently logged in

Portcullis Public Affairs teams up to launch The Portcullis Group

Joins with New Media Business Group to form agency

Portcullis Public Affairs and New Media Business Group have joined forced to create new agency The Portcullis Group.

The Group will consist of 75 specialists with a focus on five key sectors – public affairs, market access, public relations, digital and business services – and will offer clients across the government, public, private and charity sectors.

It has a particular focus on integrated communications and aims to bridge the gap between having an idea and making it a success, such as getting a product or service ready for market access, establishing a brand and fulfilling sales orders.

Ian Derbyshire, chief executive of the Portcullis Group, commented: “We've brought together all the capabilities needed to deliver our vision of becoming the centre of excellence for strategic communications and digital marketing in London.

"One of the advantages of the Group is its ability to deliver newly-integrated services and, by bringing digital marketing services into the heart of public affairs, we can connect even more effectively online with our clients' stakeholders.

“Our ability to tackle client issues, deploying the group's full marketing and digital/social media capabilities, adds considerably to the tools already available to us which have been deployed successfully for more than 25 years.”

The Group's directors include Tim Meadows-Smith, chairman of the New Media Business Group, Charles Cockburn, who founded Portcullis Public Affairs 25 years ago and now chairs the Group, and Ian Derbyshire, managing director at Portcullis Public Affairs in addition to chief executive of the Group. 

Article by
Kirstie Pickering

30th April 2015

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company
Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...